Filter
2582
Filtered Results: 2582
Text search:
drug
trial
Featured
Recommendations
238
New Publications
496
Language
Document type
No document type
1484
Studies & Reports
415
Guidelines
409
Manuals
114
Strategic & Response Plan
58
Fact sheets
43
Training Material
26
Situation Updates
11
Infographics
9
Resource Platforms
6
Brochures
5
App
1
Videos
1
Countries / Regions
India
144
Global
97
South Africa
66
Western and Central Europe
55
Kenya
45
Nigeria
41
Ethiopia
37
Uganda
35
Africa
33
Tanzania
30
Eastern Europe
29
Zambia
29
Liberia
29
Malawi
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
24
Latin America and the Carribbean
23
Zimbabwe
20
Rwanda
19
Asia
19
Bangladesh
18
Philippines
17
Myanmar / Burma
16
South–East Asia Region
15
Namibia
15
Brazil
14
Mozambique
12
East and Southern Africa
12
Colombia
11
Lesotho
11
Cambodia
10
Germany
10
West and Central Africa
10
South Sudan
9
Indonesia
9
USA
8
Middle East and North Africa
8
Thailand
7
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Syria
6
Cameroon
5
Albania
5
Senegal
5
Guinea
5
Eastern Europe and Central Asia
5
Vietnam
5
Laos
4
Burkina Faso
4
Argentina
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Venezuela
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
France
2
United Kingdom
2
Portugal
2
Belarus
2
Bolivia
2
Sri Lanka
2
Poland
2
Mali
2
Iraq
2
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
Tunisia
1
Norway
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Chad
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
700
Clinical Guidelines
323
Public Health
129
Women & Child Health
99
Key Resources
36
Pharmacy & Technologies
30
Capacity Building
18
Toolboxes
HIV
349
Mental Health
340
TB
302
COVID-19
162
NTDs
149
AMR
89
NCDs
77
Pharmacy
71
Ebola & Marburg
58
Malaria
57
Rapid Response
35
Caregiver
32
Refugee
28
Disability
24
Planetary Health
23
Health Financing Toolbox
17
Global Health Education
15
Conflict
14
Polio
10
Social Ethics
7
Cholera
6
Specific Hazards
5
Natural Hazards
5
Zika
4
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Rappart sur les populations clés.
Zambia Essential Medicines List (ZEML) 05
recommended
2020 Version
